- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$135.25 MnMarket Estimate, 2026
$144.45 MnMarket Forecast, 2034
$244.50 MnCAGR, 2026–2034
6.80%Executive Summary: Latin American Biopsy Devices Market
- Market Scope: Regional analysis of Latin America's biopsy devices sector, detailing instrument frameworks, needle biopsy variants, clinical applications, healthcare advancements, and country-level profiles for the forecast period 2026-2034.
- Market Valuation: Valued at USD 135.25 million in 2025, reaching USD 144.45 million in 2026, and projected to expand to USD 244.50 million by 2034, growing at a robust CAGR of 6.80% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of cancer, increasing demand for minimally invasive diagnostic procedures, intense competitive rivalry fueling product innovation, and expanding government-led screening initiatives.
Key Market Segment Metrics
| Category | Leading Segment (Base Position) | Fastest-Growing / High-Growth Segment |
|---|---|---|
| By Product | Consumables / Reagents (dominated the baseline market, supported by recurring procedural usage and kit requirements) | Automated / Semi-automated Instruments (anticipated at a high CAGR, fueled by technological precision and efficiency needs) |
| By Type | Needle Biopsy (held the dominant share, anchored by core and fine-needle aspiration techniques for tissue sampling) | Vacuum-Assisted Biopsy (expected to register strong growth driven by enhanced diagnostic yield and reduced repeat procedures) |
| By Application | Medical Diagnosis (captured major market share, supported by rising clinical testing and oncology requirements) | Scientific Research & Genetic Fingerprinting (projected at an extraordinary CAGR, propelled by biomedical advancements) |
| By Country | Mexico (market leader with dominant share, backed by established private healthcare networks and cross-border medical initiatives) | Brazil (key regional hub expected to register the fastest growth driven by economic development, public health expansion, and advanced diagnostic adoption) |
Major Market Players & Industry Landscape
Market Structure: Highly competitive landscape characterized by major international medical technology corporations competing intensely to advance tissue acquisition safety, precision, and regional market penetration.
Key Companies: Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc., and Intact Medical Corp.
Latin American Biopsy Devices Market Size
The Latin American Biopsy Devices Market is projected to grow from USD 135.25 million in 2025 to USD 144.45 million in 2026 and reach USD 244.50 million by 2034, registering a CAGR of 6.80% during the forecast period from 2026 to 2034.
A biopsy is a medical test performed to examine and remove cancerous tissue from the body. When a patient is suspected of having cancer, a biopsy is used to extract tissue samples to diagnose the disease.
The intense competitive rivalry among the key players to uphold their market shares is expected to fuel innovation and, in turn, help enhance the overall growth of this market. In addition, the increasing prevalence of cancer, growing demand for minimally invasive medical procedures, and increased spending for effective diagnostic procedures are pivotal factors driving the global biopsy devices market.
An increase in breast cancer screening procedures complaints is one of the key restraints for the biopsy devices market.
MARKET SEGMENTATION
This research report on the Latin American liquid biopsy market has been segmented & sub-segmented into the following categories:
By Product:
- Instruments
- Manual
- Automated
- Semi-automated
- Consumables
- Reagents
- Kits
By Type:
- Needle Biopsy
- core needle biopsy
- fine-needle biopsy
- vacuum-assisted biopsy
- Surgical Biopsy
- Incisional biopsy
- Excisional biopsy
By Application:
- Scientific Research
- Medical Diagnosis
- Agricultural Applications
- Genetic Fingerprinting
- Sex Determination
By End User:
- Pharmaceutical and Biology Industry
- Academic Research Institute
- Contract Research Organizations
- Forensic Labs
By Country:
- Mexico
- Brazil
- Argentina
- Chile
- Rest of Latin America
Geographically, in Latin America, the Mexican biopsy devices market is predicted to dominate the Latin American market and is expected to continue its dominance over the forecast period. The Brazilian biopsy devices market is estimated to grow at the highest growth rate from 2023 to 2028. The rise in demand for early cancer detection and the adoption of needle biopsy devices are fuelling the market growth. The Brazilian healthcare sector is emerging the economics along with several hospitals.
The Biopsy devices market in Argentina is following Brazil in leading prominent shares of the market. The adoption of advanced diagnostic technology in diagnostic centers and hospitals is mainly propelling the market's demand. As a result, Argentina medical devices hold approximately 25% of the market share in higher-end technology products.
In the Biopsy devices market in Peru, an increasing number of breast cancer cases is enhancing the market's growth rate. Peru improves its healthcare accessibility & quality of biopsy devices in the market. They are using fine-needle aspiration biopsy & treatment at cancer institutes. In addition, the government provides training to their hospital staff about biopsy through physicians. In 2015, private hospital nurse staff arranged the program to provide awareness about FNAB & Ultrasound devices.
KEY MARKET PLAYERS:
A few of the prominent companies in the Latin America biopsy devices market profiled in this report are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.